Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study
- PMID: 28615023
- PMCID: PMC5471999
- DOI: 10.1186/s12939-017-0601-3
Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study
Abstract
Background: Evidence suggests that Greece is among the European countries with increased trend in HCV prevalence among injecting drug users (IDUs) from 2008 to 2014. Nonetheless, the access of IDUs to treatment for Hepatitis C Virus (HCV) is very limited while the risk of co-infection and transmission remains high. In an effort to better understand the inhibitors to HCV treatment, the present study aimed to investigate the main barriers to access in a sample of IDUs.
Methods: The cross-sectional study was carried out between July and September 2015 using a 23-items questionnaire. Participants were recruited from urban primary services, mobile health vans, community health services, day-care centers as well as during street work, located in Athens, Greece. Inclusion criteria were age above 18 years, understanding and speaking Greek sufficiently, HCV diagnosis, intravenous drug use. Data collection was carried out by health professionals of Praksis, a non-governmental organization. For the comparisons of proportions chi-square and Fisher's exact tests were used.
Results: The study sample consisted of 101 HCV patients, 68% male. More than 80% of study participants experienced barriers in accessing their doctor and medication during the past 12 months. The most common obstacles in accessing a doctor were "delay in making the appointment and "difficulties in going to the doctor due to health condition or lack of means of transport". Access to physician or medication was not differed according to gender, but significant differences were found according to economic status and health insurance coverage. 56.1% of participants reported loss or treatment delay due to barriers to treatment. The majority of participants had deteriorated financial status, health status, access to health services and medication, higher financial burden for health services, worse mental health and lower adherence to medical instructions in 2015 compared to 2009.
Conclusions: The findings from the present study revealed that the vast majority of IDUs experience significant barriers in seeking HCV care in Greece, thus highlighting the need for immediate action in this particular area due to the high risk of co-infection and transmission.
Keywords: Barriers; Economic crisis; Greece; HCV; Healthcare; Hepatitis C; Injecting drug users; Patient access; Pharmaceuticals; Recession.
Figures
Similar articles
-
Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.AIDS Care. 2006 Oct;18(7):690-3. doi: 10.1080/09540120500359330. AIDS Care. 2006. PMID: 16971276
-
Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.Int J STD AIDS. 2013 Aug;24(8):619-25. doi: 10.1177/0956462413477553. Epub 2013 Jul 19. Int J STD AIDS. 2013. PMID: 23970571
-
Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.Lancet Infect Dis. 2015 Jan;15(1):36-45. doi: 10.1016/S1473-3099(14)71045-X. Epub 2014 Dec 3. Lancet Infect Dis. 2015. PMID: 25486851 Free PMC article.
-
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.Int J Drug Policy. 2007 Oct;18(5):417-25. doi: 10.1016/j.drugpo.2007.01.013. Epub 2007 Feb 20. Int J Drug Policy. 2007. PMID: 17854731 Review.
-
Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: a systematic review.Int J Drug Policy. 2011 Mar;22(2):102-8. doi: 10.1016/j.drugpo.2010.10.007. Epub 2010 Nov 26. Int J Drug Policy. 2011. PMID: 21112759 Review.
Cited by
-
Overall mortality trends in Greece during the first period of austerity and the economic crisis (2009-2015).Hippokratia. 2022 Jul-Sep;26(3):98-104. Hippokratia. 2022. PMID: 37324039 Free PMC article.
-
Access of People Living with HIV to Testing Services in Greece: A Challenge for Equity in Care.Int J Environ Res Public Health. 2022 Nov 2;19(21):14353. doi: 10.3390/ijerph192114353. Int J Environ Res Public Health. 2022. PMID: 36361228 Free PMC article.
-
Citizen Preferences for Primary Health Care reform in Greece.Hippokratia. 2019 Jul-Sep;23(3):111-117. Hippokratia. 2019. PMID: 32581496 Free PMC article.
-
HCV infection status and care seeking among people living with HIV who use drugs in Vietnam.AIDS Care. 2020 May;32(sup2):83-90. doi: 10.1080/09540121.2020.1739209. AIDS Care. 2020. PMID: 32297556 Free PMC article.
-
Aiming towards hepatitis C virus elimination in Greece.Ann Gastroenterol. 2019 Jul-Aug;32(4):321-329. doi: 10.20524/aog.2019.0375. Epub 2019 Apr 5. Ann Gastroenterol. 2019. PMID: 31263353 Free PMC article.
References
-
- EMCDDA . Hepatitis C among drug users in Europe: epidemiology, treatment and prevention. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction; 2016.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous